Besides the H5N1 vaccine approved by the US Food and Drug Administration in April, "a number of the most advanced candidate vaccines against H5N1 avian influenza might be registered within six months to two years," the WHO said in a question-and-answer bulletin on pandemic flu vaccines. Besides the H5N1 vaccine approved by the US Food and Drug Administration in April, "a number of the most advanced candidate vaccines against H5N1 avian influenza might be registered within six months to two...

Ghanaian authorities are alarmed by the growing pace of the avian flu s pace in the country, especially Tema Municipality where three outbreaks were recorded within a week. Most Ghanaians fear that the virus might spread to large poultry farms in Tema Municipality, leading to scarcity of poultry products. The head of Ghana s avian flu surveillance team, Darlington Owusu, confirmed the destruction of thousands of crates of eggs. The West African country aims to eradicate bird flu but fear...

Many have only started to recover after losing their flock to bird flu and now they must sit and wait to see which rivers crest first. Poultry farmers are growing frustrated with what little they can do to prepare. He says the unpredictability of the rivers are frustrating for farmers who are trying to organize a way out for their chickens, but many cannot be moved, and if and when the water rises, many flocks will be lost. News1130 Meteorologist Russ Lacate agrees with flood forecasters...

The Hindu News Update Service. As of now we have initiated efforts for its which would take about three years and then these genes would be transferred into developing disease resistant chicken which may again take couple of years," a senior scientist of UP-based Central Avian Research Institute told PTI. As of now we have initiated efforts for its which would take about three years and then these genes would be transferred into developing disease resistant chicken which may again take...

The European Union's advisory panel on new drugs has recommended approval for Novartis' new cell based seasonal flu vaccine Optaflu which suggests full approval is likely to go ahead in the next two or three months. According to a press release from the European Medicines Agency (EMEA), the Committee for Medicinal Products for Human Use (CHMP), which reviews applications for all 27 countries in the EU as well as Iceland and Norway, has given a "positive opinion" for the Swiss...